Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia [9]

Revista Brasileira de Psiquiatria

Volumn 29, Issue 1, 2007, Pages 92-

  Pondé, Milena Pereira ^a   Novaes, Camila Marinho ^a,b  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b FAPESB Fund de Amparo a Pesquisa do Estado da Bahia Res Support Found of the State of Bahia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; ESTAZOLAM; HALOPERIDOL; MEMANTINE; PROMETHAZINE; TRIFLUOPERAZINE;

ADD ON THERAPY; AGED; AGGRESSION; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MEMORY DISORDER; MOOD; PARANOIA; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SPEECH DISORDER; TREATMENT RESPONSE;

AFFECT; AGED; ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MEMANTINE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SCHIZOPHRENIA, PARANOID;

EID: 34147160318     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462007000100028     Document Type: Letter

References (2)

1. Gama CS, Antunes P, Moser C, Belmonte-de-Abreu PS. Memantine as an adjunctive therapy for schizophrenia negative symptoms. Rev Bras Psiquiatr. 2005;27(3):257-8.
2. Gaszner P. Clinical observations with aripiprazole in schizophrenia. Neuropsychopharmacol Hung. 2006;8(1):29-32.